EverBridge Group Partners with Cosmotec to Transform Medical Device Market in Japan

EverBridge Group and Cosmotec Forge Historic Partnership

In a significant move, EverBridge Group announced an exclusive marketing partnership with Cosmotec Inc., a wholly-owned subsidiary of M3, Inc., specifically targeting the Japanese market. This collaboration represents a pivotal moment in EverBridge's global expansion strategy and further strengthens its international influence in medical technology.

EverBridge Group is renowned for its proprietary research and development capabilities, as well as strict regulatory compliance. The alliance with Cosmotec also enhances the capabilities of Cosmotec’s leading digital marketing platform. This partnership aims to speed up the entry of international medical devices into the Japanese market, facilitating tailored interactions with clinical end-users.

Suguru Ominato, CEO of Cosmotec, commented, “EverBridge's product portfolio demonstrates exceptional clinical efficiency and intuitive design, perfectly aligning with the advanced therapeutic solutions that Japanese medical professionals seek.” The integration of M3's academic platforms with Cosmotec’s local marketing expertise promises to accelerate the acceptance of innovative medical devices in Japan.

Jay Wang, CEO of EverBridge Group, emphasized, “Cosmotec’s digital marketing model offers both efficiency and accessibility, aligning seamlessly with our vision of equitable healthcare innovation.” He underscored that navigating Japan's stringent technical and regulatory landscape not only delivers transformative solutions to patients but also enhances EverBridge's global R&D synergy.

This partnership underscores EverBridge Group's commitment to reducing barriers to advanced care through innovation and collaboration in the ecosystem. Their mission is to provide global healthcare professionals and patients with improved treatment options through advanced, accessible solutions.

About EverBridge Group

Established as a leading medical technology group in Asia, EverBridge Group is dedicated to delivering cutting-edge medical technologies to its global clients. The company's rapidly expanding portfolio focuses on three primary therapeutic areas: peripheral vascular, neuroscience, and oncology. Supported by six specialized R&D centers, they provide top-tier OEM/ODM services in areas such as balloons, catheters, stents, surface engineering, and active medical devices.

EverBridge Group collaborates extensively with leading companies worldwide, bridging the gap for innovative medical technologies between Asia and the rest of the world. Their objective is to enhance global healthcare options by providing advanced and accessible treatment solutions. For more information, please visit www.everbridgemed.com.

With this collaboration, both EverBridge Group and Cosmotec are set to make significant strides in the Japanese medical device market, ultimately benefiting healthcare providers and patients alike. This partnership stands as a testament to their commitment to innovation and the imperative of addressing healthcare challenges through effective solutions.